A Study to Evaluate Critical Care and Palliative Care Medicine Together in the ICU

Overview

About this study

Will earlier palliative care medicine consultation in the ICU result in decreased length of stay in the ICU and hospital, as well as, increased patient and family satisfaction. Secondary questions to be answered is if this early consultation changes ICU and hospital death, discharge destinations, hospice admissions, code status changes, and withdrawal of life sustaining interventions.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

  • Inclusion Criteria:
  1. Age >80 years
  2. Apache II score >14
  3. SOFA score > 9
  4. Pre-existing functional dependency (admitted from ALF, SNF, LTAC, etc.)
  5. Late stage dementia (bed-bound, nonverbal, incontinent, or unable to self-nourish/tube feed)
  6. Stage 4 metastatic disease
  7. Consideration to place permanent feeding tube or trach
  8. Recurrent ICU admissions in the past year
  9. Post-cardiac arrest
  10. End-stage disease (lung, ESRD, ESLD)
  11. ICU perceived need

Exclusion Criteria:

  • If the patient has already seen palliative care medicine for any reason.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Jacksonville, Fla.

Mayo Clinic principal investigator

John Moss, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions